Chelsea, MA – Beth Israel Deaconess Medical Center, part of Beth Israel Lahey Health, expanded its ambulatory COVID-19 testing locations today with the addition of a site at Beth Israel Deaconess HealthCare-Chelsea. This site will be supporting patients within the Beth Israel Lahey Health system by performing COVID-19 ambulatory testing by appointment only. The site located at 1000 Broadway in Chelsea, will offer testing seven days a week in both English and Spanish.
"Our communities in Chelsea and Revere have by far the highest rates of infection in the state of Massachusetts," said Jose Abrego, MD, an internist at BID-Chelsea and Medical Director of BID-Chelsea's ambulatory testing site. "There are many reasons why these communities are seeing such high rates of infection—mainly due to their high-density populations where overcrowded housing makes isolation difficult. By expanding testing for COVID-19, we hope to get a more accurate assessment of the health crisis in these communities. We can then identify those at highest risk of complications early while partnering with city and state officials to help decrease the likelihood of spreading the virus."
